Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Nephrology
Published in: Journal of Nephrology 5/2022

25-02-2022 | Sarcoidosis | Lessons for the Clinical Nephrologist

Pandemic affects the uninfected: hypercalcemia in a peritoneal dialysis patient due to protective equipment shortage

Authors: Sanjeev Shrestha, Raza Zaidi, Conrad Schuerch, Gurmukteshwar Singh

Published in: Journal of Nephrology | Issue 5/2022

Login to get access

Excerpt

A 59-year-old male with end-stage kidney disease (ESKD) from diabetes, human immunodeficiency virus (HIV) infection, coronary artery disease, and hypertension was stable on continuous cycler peritoneal dialysis for about 2 years. His mineral bone disorder had been well controlled on calcium acetate 667 mg with meals, 0.25 mcg calcitriol and 1000 Units of cholecalciferol daily. In the setting of worsening hyperphosphatemia, attributed to dietary indiscretion at the time, calcium acetate was increased and calcitriol stopped. His health insurance did not cover non-calcium-based phosphate binders. …
Appendix
Available only for authorised users
Literature
1.
2.
3.
Mf C, Ds S (2003) A practical approach to hypercalcemia. Am Fam Physician 67(9):1959–1966
4.
5.
6.
7.
8.
9.
Metadata
Title
Pandemic affects the uninfected: hypercalcemia in a peritoneal dialysis patient due to protective equipment shortage
Authors
Sanjeev Shrestha
Raza Zaidi
Conrad Schuerch
Gurmukteshwar Singh
Publication date
25-02-2022
Publisher
Springer International Publishing
Published in
Journal of Nephrology / Issue 5/2022
Print ISSN: 1121-8428
Electronic ISSN: 1724-6059
DOI
https://doi.org/10.1007/s40620-022-01272-6

Other articles of this Issue 5/2022

Journal of Nephrology 5/2022 Go to the issue

Case Report

Long term central venous catheters for haemodialysis causing an extra-cardiac right-to-left shunt

Review

Contrast-enhanced ultrasound in peritoneal dialysis: when and how to perform it

Commentary

Implementing referral systems for nephrology services: real world practice versus guidelines

original Article

Early morning hemodynamic changes and left ventricular hypertrophy and mortality in hemodialysis patients

Editorial

Outside the box. The history of dialysis teaches a lesson of freedom

original Article

Intradialytic hypotension and objectively measured physical activity among patients on hemodialysis
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits